ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CABA Cabaletta Bio Inc

12.09
1.45 (13.57%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cabaletta Bio Inc CABA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.45 13.57% 12.09 10:00:00
Open Price Low Price High Price Close Price Previous Close
10.60 10.555 12.69 12.41 10.645
more quote information »

Recent News

Date Time Source Heading
21/3/202422:00GLOBECabaletta Bio Reports Fourth Quarter and Full Year 2023..
20/3/202422:00GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
05/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:00GLOBECabaletta Bio to Participate in Upcoming Investor..
15/2/202401:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202410:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202408:36EDGAR2Form 8-K - Current report
02/2/202408:30GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
01/2/202400:00GLOBECabaletta Bio to Participate in the Guggenheim Healthcare..
20/1/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:11EDGAR2Form 8-K - Current report
08/1/202423:00GLOBECabaletta Bio Receives Additional FDA Fast Track..
03/1/202400:00GLOBECabaletta Bio to Present at the 42nd Annual J.P. Morgan..
20/12/202312:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202322:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
29/11/202308:30GLOBECabaletta Bio to Participate in the 6th Annual Evercore ISI..
29/11/202306:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
22/11/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202308:16EDGAR2Form 144 - Report of proposed sale of securities
09/11/202323:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:12EDGAR2Form 8-K - Current report
09/11/202323:00GLOBECabaletta Bio Reports Third Quarter 2023 Financial Results..
07/11/202300:15BWCellares and Cabaletta Bio Partner to Evaluate Automated..
06/11/202323:55DJNCabaletta Bio Gets FDA OK to Study CABA-201 in Generalized..
06/11/202323:03EDGAR2Form 8-K - Current report
06/11/202323:00GLOBECabaletta Bio Receives FDA Clearance of CABA-201 IND..
30/10/202323:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
20/10/202310:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202307:03EDGAR2Form 144 - Report of proposed sale of securities
02/10/202322:38EDGAR2Form 8-K - Current report
02/10/202322:00GLOBECabaletta Bio Receives FDA Clearance of IND Application for..
21/9/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202306:23EDGAR2Form 144 - Report of proposed sale of securities
19/9/202322:00GLOBECabaletta Bio to Participate in Upcoming Investor..
05/9/202322:45EDGAR2Form 8-K - Current report
30/8/202322:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
23/8/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202322:03EDGAR2Form 8-K - Current report
22/8/202322:00GLOBECabaletta Bio and WuXi Advanced Therapies Announce Expansion..
22/8/202306:19EDGAR2Form 144 - Report of proposed sale of securities
10/8/202321:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202321:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202321:16EDGAR2Form 8-K - Current report
10/8/202321:00GLOBECabaletta Bio Reports Second Quarter 2023 Financial Results..
24/7/202322:06EDGAR2Form 8-K - Current report
24/7/202322:00GLOBECabaletta Bio Appoints Global Commercial Leader Shawn..

Your Recent History

Delayed Upgrade Clock